RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Thomas A. Mellman to Antipsychotic Agents

This is a "connection" page, showing publications Thomas A. Mellman has written about Antipsychotic Agents.
Connection Strength

0.696
  1. David D, De Faria L, Mellman TA. Adjunctive risperidone treatment and sleep symptoms in combat veterans with chronic PTSD. Depress Anxiety. 2006; 23(8):489-91.
    View in: PubMed
    Score: 0.258
  2. David D, De Faria L, Lapeyra O, Mellman TA. Adjunctive risperidone treatment in combat veterans with chronic PTSD. J Clin Psychopharmacol. 2004 Oct; 24(5):556-9.
    View in: PubMed
    Score: 0.237
  3. Marshall PB, Mellman TA, Nguyen SX. Neuroleptic malignant syndrome with the addition of aripiprazole to olanzapine. Am J Psychiatry. 2008 Nov; 165(11):1488-9.
    View in: PubMed
    Score: 0.078
  4. Mellman T, Lydiard RB. Posttraumatic stress disorder: characteristics and treatment. J Clin Psychiatry. 2008 Jan; 69(1):e2.
    View in: PubMed
    Score: 0.074
  5. Clark RE, Bartels SJ, Mellman TA, Peacock WJ. Recent trends in antipsychotic combination therapy of schizophrenia and schizoaffective disorder: implications for state mental health policy. Schizophr Bull. 2002; 28(1):75-84.
    View in: PubMed
    Score: 0.049
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support